 |
Equity Research Analysts
Ching-Yi LinVice President Ching-Yi Lin is a research analyst covering biotechnology/pharmaceutical companies. She has a background in various areas, including finance and technology/life science. She has worked in macroeconomics and advisory in corporate finance at Millennium Partners, Wachovia Securities and Credit Suisse, respectively. Ching-Yi is also an inventor and developer of technology, including medical devices, and has been awarded patents in various areas of technology by the US Patent and Trademark Office. Additionally, she has worked in research labs at Indiana University Medical Center and University of Cincinnati, been an advisor to venture capital firms in life sciences and taught chemistry. Ching-Yi graduated with two undergraduate degrees from Indiana University: B.S. in Biology/Honors Program and B.A. in Economics with the equivalent of minors in Chemistry and Journalism. She has an MBA from Columbia Business School where she graduated Beta Gamma Sigma (Honors), as well as a Master’s focusing in Finance from London Business School.
|
Jesup & Lamont Securities Corporation is a member of FINRA (www.finra.org) and a member of SIPC (www.sipc.org). SIPC provides protection of up to $500,000, including a maximum of $100,000 for cash balances. SIPC does not guarantee the future value of any security.
